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ABSTRACT: Ceramides from sphingolipid breakdown, and other sphingolipid metabolites, mediate cellular signalling in 
infectious and other diseases. Therefore, inhibitors of sphingomyelinases (SMases), hold promise as prospective therapeutic 
agents.  Considering the potential therapeutic utility, this in vitro study explored the sphingomyelinase inhibitory, and free 
radical scavenging potential of five Nigerian medicinal plant leaf extracts, purported to have efficacy against diseases, including 
HIV/AIDS. The extracts’ sphingomyelinase inhibitory potencies were assessed colorimetrically and their free radical scavenging 
capabilities were assayed by the ability to quench 2,2‐diphenyl‐1‐picrylhydrazyl (DPPH) radical and superoxide anion (O2
.‐) 
radical. Considering their IC50 (μg/ml) values, the extracts inhibited the biochemical activity of sphingomyelinase in a dose-
dependent manner, relative to imipramine the standard inhibitor (IC50 38.5 ± 2.4 μg/ml). With Aloe vera as least inhibitory, 
inhibition increased as follows: Aloe vera (Asphodelaceae) (1132 ± 10.8) < Senna siamea (Fabaceae) (992.2 ± 11.2) < Azadirachta 
indica (Meliaceae) (984 ± 7.4) < Landolphia owariensis (Apocynaceae) (146.3 ± 9.4) < Stachytarpheta angustifolia (Verbenacae) 
(100.3 ± 8.7). DPPH radical scavenging relative to ascorbic acid standard increased as:  A. indica < A. vera < S. siamea < S. 
angustifolia < L. owariensis; and superoxide anion quenching, relative to standard rutin increased as: A. vera < S. angustifolia < L. 
owariensis < S. siamea < A. indica. These results showed that the most potent SMase inhibitor was S. angustifolia; whereas, for 
DPPH radical scavenging and superoxide inhibition, the most potent of the five extracts were L. owariensis and A. indica 
respectively. These extracts deserve further investigation into their biological effects. 
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INTRODUCTION 
Sphingomyelinases (SMases) hydrolyze sphingomyelins 
yielding ceramide and phosphocholine (Barth et al., 2012; Finnegan 
et al., 2004; Finnegan et al., 2007; Fox et al, 2006; Smith and 
Schuchman, 2008; Hofmeister et al., 1997). Ceramide, a unique two-
tailed amphipathic lipid (two hydrophobic chains on one polar 
head) has been found to play profound roles in the normal as well 
as in the pathophysiological states of the individual (Castillo et al., 
2007; Grassme et al., 2003) and in the organism under toxicological 
insult (Ichi et al., 2009; Rebillard et al., 2008). Thus, as has been 
reviewed (Fox et al., 2006;  Ogretmen and Hannum, 2004; Smith 
and Schchman, 2008) ceramide is a major mediator in 
inflammation (Philipp et al., 2010), growth and development, 
differentiation and apoptosis (Jones et al., 1999). It has also shown 
an effect in neurological disorders such as Alzheimer‟s disease and 
Niemann-Pick disease. In cancer, its pro-apoptotic potency causes 
tumour-suppressor and antiproliferative effects on various cancer 
cells (Ogretmen and Hannum, 2004; Reynolds, et al., 2004). There 
are also reports revealing its effects on atherosclerosis and heart 
failure (Adamy et al., 2007), endotoxic shock (Józefowski et al., 
2010) and ischemia-reperfusion injury (Llacuna et al., 2006).  
These roles emanate from the ability of ceramide to function as 
a metabolic second messenger in a plethora of cell signalling events 
(Barth et al., 2012; Finnegan et al, 2004; Fox et al., 2006). The 
molecule also does partition specifically and physicochemically 
into membrane lipid microdomains called “lipid rafts” (Grassme et 
al., 2003; Ogretmen and Hannum, 2004; Smith and Schuchman, 
2008), thereby creating the potential for lateral phase separations 
in the membrane lipid bilayer. A number of specific and special 
functions of the membrane are predicated on the presence or 
transient occurrence of such lateral phase separation events. Such 
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have been implicated in the modulation of HIV infectivity 
(Finnegan et al., 2004, 2007; Fox at al., 2006) and, in the mouse as 
well as in mammalian cultured cells, modulation of Pseudomonas 
aeruginosa infection (Grassme et al., 2003). Involvement of lateral 
phase separations in membrane-associated processes appears to be 
universal, and applies in varied ways to various organisms (Eze, 
1991). 
Copious yields of ceramide from the activation of Mg2+-
dependent neutral sphigomyelinase (Mg2+-NSMase) have been 
reported in cultured human neuroblastoma cells and primary 
cortical neurons. This forms part of the pro-inflammatory effects of 
the cytokine, tumour necrosis factor alpha (TNF-α) (Barth et al., 
2012). This ceramide production is a crucial primary step in the 
TNF-α – induced superoxide production by NADPH oxidase 
which leads to damage to neurons via the resulting oxidative 
stress. Such events also underlie the mechanism of other pro-
inflammatory cytokines like interleukin 1 (IL-1) (Grassme et al., 
2003; Hofmeister et al., 1997), and IL-6 (Smith and Schuchman, 
2008).  
Ceramides may also participate in the induction of 
neurodegeneration involved in the aetiology and pathogenesis of 
cognitive impairment associated with type 2 diabetes mellitus and 
non-alcoholic steatohepatitis (NASH) (de la Monte et al., 2010). 
They are implicated as causative agents in the pathogenesis of 
emphysema in smokers and in animal models as well (Petrache et 
al., 2005). In addition, ceramide has also been identified as an 
endogenous pyrogen, a common endogenous metabolite that 
mediates the rapid phase of the fever response induced by IL-1β or 
by such exogenous pyrogens as lipopolysaccharides (LPS) of the 
gram-negative bacteria cell envelope (Sanchez-Alavez et al., 2006). 
Adamy et al., (2007) reported activation of neutral 
sphingomyelinase (NSMase) in the rat model of chronic heart 
failure, and that inhibition of this NSMase, but not acid 
sphingomyelinase (ASMase), promoted positive outcome in N-
acetylcysteine (NAC) therapy of the failing heart. Cells infected 
with P. aeruginosa produce activated ASMase which protects 
against the infection, balancing the production of IL-1 with 
optimum internalization and destruction of the pathogen 
(Grassme et al., 2003). 
Enhanced immune activation is synonymous with HIV 
infection and disease progression (Card et al., 2009; Catalfamo et al., 
2008; Koesters et al., 2004; Sousa et al., 2002). In studies of HIV-
resistant commercial sex workers, Card and associates (2009) have 
observed that decreased immune activation is consistent with 
HIV-resistance. Immune activation entails induction of pro-
inflammatory factors such as cytokines (Koesters et al., 2004; 
Grassme et al., 2003), and oxidative stress (Gil et al., 2003). 
Enhancement of several indices of oxidative stress has been 
demonstrated in HIV/AIDS patients (Gil et al., 2003).  
Ceramide as a pro-inflammatory metabolite (Barth et al., 2012; 
Grassme et al., 2003) is capable of creating and/or augmenting 
oxidative stress and inflammatory status in the individual, such as 
the HIV/AIDS patient (Gil et al., 2003). Thus, antioxidants, as well 
as anti-inflammatory and other agents that ameliorate these 
situations are expected to make the patient feel better in health. 
However, the role of Ceramide and other participating 
sphingolipid metabolites in HIV infection and AIDS is 
controversial when viewed in detail. Ceramide inhibits infection in 
various ways, e.g., facilitating the containment and inactivation of 
“internalized” HIV [see Fox et al., (2006) for review]. But in the 
advanced AIDS patient, this lipid contributes to the pathogenesis 
of HIV-associated dementia (HAD): It is produced via activation of 
neutral SMase by HIV type 1 gp120, and induces apoptosis and 
neuropathology through oxidative stress, resulting in HAD (Jana 
and Pahan 2004). 
Therefore, there is an emerging rationale that the study of 
sphingomyelinases may provide some insight into the control of a 
number of major disease conditions. This notion has, therefore, 
created the need to explore novel functional inhibitors of the 
activity of these sphingomyelinases as therapeutic agents, as 
recently published by Kornhuber et al. (2011) for acid 
sphingomyelinase. Given the merits of sourcing efficacious, 
inexpensive, and safe medicines for the world‟s masses (WHO 
2008), we had earlier proposed strategies for studying and 
characterizing plants of traditional medicine utility (Eze et al., 
1993). In line with this, the present in vitro study focuses on the 
modulation of sphingomyelinase, and the scavenging of free 
radicals, including superoxide (agents of oxidative stress), by 
extracts from selected herbs in use by Nigerian traditional 
medicine practitioners, and for which claims of efficacy against 
various infectious and non-communicable diseases have been made 
(see Table 1). 
MATERIALS AND METHODS 
Preparation of leaf extracts 
The leaves of Aloe vera (Asphodelaceae), Landolphia owariensis 
(Apocynaceae), Senna siamea (Fabaceae), Stachytarpheta angustifolia 
(Verbenacae), and Azadirachta indica (Meliaceae)  were collected, 
identified, processed, and extracted with 80% methanol; and the 
extracts were concentrated and stored at 4oC until use (Awah et al., 
2012). 
Chemicals 
The solvents ethanol and methanol were purchased from EMD 
Biosciences (Gibbstown, NJ). L-ascorbic acid, and 2,2-diphenyl-1-
picrylhydrazyl (DPPH) free radical, were purchased from Fluka 
Chemicals. Rutin, ethylenediaminetetraacetic acid (EDTA), 
phosphate buffered saline (PBS), riboflavin, methionine, and the 
sphingomyelinase enzymatic assay kit were all purchased from 
Sigma Chemical Co. (St. Louis, MO). Ascorbic acid, rutin, and 
imipramine were used as standards for comparing the effects of the 
various leaf extracts respectively as free radical scavenger, 
superoxide quencher, or sphingomyelinase inhibitor. 
Enzymatic assay for sphingomyelinase 
The sphingomyelinase assay is based on the enzymatic 
hydrolysis of trinitrophenylaminolauroyl (TNPAL)-sphingomyelin 
to choline phosphate and trinitrophenylaminolauroyl (TNPAL)-N-
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acylsphingosine, catalysed by sphingomyelinase from a bacterial 
source. The assay was performed as per the manufacturer‟s 
protocol (Sigma Chemical Co.). Briefly, the reagents for this assay 
were prepared fresh and referred to as reagents A – F. Reagent „A‟ 
was Tris HCl buffer (500 mM) with magnesium chloride (20 mM) 
prepared in deionized water, pH 7.4 at 37 oC. Reagent „B‟ was 
trinitrophenylaminolauroyl-sphingomyelin substrate solution 
(TNPAL-sphingomyelin). Immediately before use, 0.045 ml (0.05 
mg) of the substrate was pipetted into a one-dram glass vial on ice. 
The solvent was evaporated from the material with nitrogen gas. 
Reagent „C‟ was 0.2 % (v/v) Triton X-100 solution prepared in 10 
ml in deionized water. Reagent „D‟ was isopropanol : heptane : 
H2SO4 solution (40:10:1) (ISOPRO). Solution „E‟ was heptane while 
reagent „F‟ was the sphingomyelinase enzyme solution prepared 
immediately before use at a concentration of 1.0 unit/ml in cold 
Reagent „A‟. One-dram glass vials were labelled test, blank and 
control. To each of them, TNPAL-sphingomyelin (45 μl) was 
pipetted and the solvent evaporated from the material with 
nitrogen gas until the substrate became a yellow film on the glass 
vial. Immediately, the vial was returned to ice and capped. To the 
films, 180 μl of reagent „A‟ (buffer, pH 7.4) and 200 μl of reagent „C‟ 
(Triton X-100) were added and the solutions were mixed by 
swirling to remove the yellow substrate affixed to the glass and 
equilibrated at 37oC for 2 min. Then, 10 μl of extract solution (10, 
20 or 50 μg/ml) was added to both the test and the blank vial, 
followed by reagent „F‟ (enzyme solution) to the test and control 
vials only. The solutions were swirled and further incubated for 2 
min and 1500 μl of reagent „D‟ (ISOPRO) added to each vial. The 
vials were capped and placed on ice and uncapped immediately, 
before adding deionized water (800 μl) and heptanes (1800 μl). 
The caps were replaced and vials shaken vigorously for 5 min by 
hand and allowed to sit at 25oC. The upper layer was removed and 
transferred into suitable quartz cuvettes, and absorbance values 
read at 330 nm. The sphinogomyelinase inhibitory effect of the 
extracts was calculated as per the formula: 
 
Where A0 and As represent absorbance of the control and 
absorbance of the test sample respectively. The decrease in SMase 
activity measured has been treated here as due to inhibition. It is 
conceivable that part of the decrease could have been due to 
inactivation which was not assessed in this work. However, this 
does not alter the conclusions proffered. 
Free radical inhibition assays 
Quantitative DPPH radical-scavenging assay 
Scavenging activity on DPPH free radicals by the extract was 
assessed according to the method reported by Gyamfi et al. (1999) 
with slight modifications (Awah et al 2010).  In this present work, 
% inhibition, of DPPH radical-scavenging activity was calculated 
according to the equation: 
 
Where, as in Awah et al. (2010), A0 is the absorbance of the control, 
and As is the absorbance of the tested sample. The IC50 value 
represented the concentration of the extract that caused 50 % 
inhibition of DPPH radical and was calculated by linear regression 
of plots, where the abscissa represented the concentration of tested 
sample and the ordinate the average percent of inhibitory activity 
from three replicates. 





This assay was based on the capacity of the extract to inhibit 
the photochemical reduction of nitro blue tetrazolium (NBT) 
(Beauchamp and Fridovich, 1971) and the method of Martinez et al., 
(2001) to determine superoxide dismutase as modified by Awah et 
al. (2010).  The percentage inhibition of superoxide generation was 
also estimated by comparing the absorbance of the control and that 
of the reaction mixture containing test sample as per the equation: 
 
Where A0 is the absorbance of the control, and As is the absorbance 
of the test sample (Awah et al., 2010). 
Plant species 
and family 
Part used  Claims of Potency or Traditional 
use 
(As per published literature and from 




Leaves  Malaria fever, gonorrhea, other 
microbial infections, ulcer, 
inflammation, analgesic, antiviral 




Leaves Malaria, gonorrhoea, hypertension, 
diabetes, herpes and rhinitis, 
laxative, bacterial infections, 
inflammation, HIV (Odugbemi et al., 




Leaves Purgative, guinea worms, hair care, 
skin diseases, wound, diabetes, 
amenorrhoea, breast cancer, immune 







Leaves Diabetes, microbial infections, anti-
infective, inflammation, sexually 
transmitted infections, dropsy, HIV 




Leaves Malaria, jaundice, syphilis, 
helminths, skin disease, laxative, 
sore throat, HIV (Awah et al., 2011; 
Mbah, et al., 2007 ; Udeinya et al., 
2006; http://www.herbcu.com ; 
Odugbemi et al., 2007) 
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Statistical analysis 
Data were analysed using one-way analysis of variance 
(ANOVA) at 0.05 level of significance using the statistical package 
for social sciences (SPSS) version 17.0 for windows software 
package. Linear regression plots were done using Microsoft Excel 
for Windows Vista. All the results are expressed as mean ± 
standard error of the mean (SEM) (n = 3). 
RESULTS 
Sphingomyelinase inhibitory potency of extracts 
As shown in Fig. 1 and Table 2, the selected plant extracts 
inhibited sphingomyelinase in a dose-dependent manner compared 
to imipramine, a standard sphingomyelinase inhibitor. S. angustifolia 
showed the highest inhibitory potency (IC50 = 100.3 ± 8.7μg/ml) 
with maximal inhibition of 26 % compared to 49 % for imipramine 
(IC50 = 38.5 ± 2.4 μg/ml) at a concentration of 100 μg/ml.  A. vera had 
the least inhibitory potency of 18 % at the concentration of 100 
μg/ml. 
 
Free radical inhibition assays 
Effect of extracts on DPPH radical 
 All extracts showed significant dose-dependent DPPH radical 
scavenging capacity (Fig. 2). Among them, L. owariensis was most 
efficient, inhibiting 92.3 ± 4.5 % of DPPH at a concentration of 125 
μg/ml compared to ascorbic acid which inhibited 94.2 ± 3.2 % at 
the same concentration. As shown by their IC50 values (Table 3), 
the DPPH radical scavenging efficiency of the extracts increased as 
follows: A. indica < A. vera < S. siamea < S. angustifolia < L. owariensis. The 
radical scavenging ability of the plant extracts could be as a result 
of the presence of secondary metabolites such as phenolic 
compounds (Awah et al., 2010). 
TABLE 2 IC50 for sphingomyelinase inhibitory potency of 
selected extracts 
Extract / Standard drug IC50 (μg/ml) 
Landolphia owariensis 146.3 ± 9.4 
Senna siamea 992.2 ± 11.2 
Aloe vera 1132 ± 10.8 
Stachytarpheta angustifolia 100.3 ± 8.7 
Azadirachta indica  984 ± 7.4 
Imipramine 38.5 ± 2.4 
 
Effect of extracts on superoxide (O2
.-) anion radical 
All the plant extracts inhibited the formation of reduced NBT 
in a dose-related manner. As shown in Fig. 3, A. indica showed the 
maximal O2
.- anion inhibitory activity of 80.7 ± 1.4 % at the 
concentration  of 250 μg/ml, followed by L. owariensis (78.6 ± 2.8 %, 
at 250 μg/ml), while A. vera  showed the lowest inhibitory activity 
(45.8 ± 5.2 %, at 250 μg/ml) compared to rutin (94.0 ± 2.2 %, at 250 
μg/ml). The O2
.- scavenging effect of the extracts could culminate 
in the prevention of .OH radical formation since O2
.- and H2O2 are 
required for .OH radical generation. Superoxide anion (O2
.–) forms 
from the inadvertent single electron reduction of molecular oxygen 
in the mitochondrial (or other related) oxidative electron transport 
chain (Grivennikova & Vinogradov, 2006). It is also produced in 
large amounts as a cellular immune response against various types 
of infection, and in other disease conditions (Eze et al., 1993 for 
review). Superoxide then becomes the precursor of the other 
reactive oxygen species: hydrogen peroxide (H2O2), hydroxyl free 
radical (.OH), hypohalite (e.g., OCl-), and others. 
DISCUSSION 
The potencies of the leaf extracts of the following five Nigerian 
medicinal plants for quenching free radicals (DPPH and 
superoxide anion radicals), and for inhibiting the enzyme, 
sphingomyelinase (SMase), have been studied: A. vera 
(Asphodelaceae), L. owariensis (Apocynaceae), S. siamea (Fabaceae), 
S. angustifolia (Verbenacae), and A. indica (Meliaceae). In a dose-
dependent manner, the five leaf extracts each inhibited SMase, and 
scavenged free radicals, including superoxide radical, to varying 
degrees. The most potent SMase inhibitor was S. angustifolia; 
whereas, for DPPH radical scavenging and superoxide inhibition, 
the most potent of the five extracts were L. owariensis and A. indica 
respectively. Scavenging of superoxide prevents its fast (diffusion-
controlled) combination with nitric oxide [also produced under 
pro-inflammatory conditions (Codoner-Franch et al., 2011)] to form 
peroxynitrite ONOO-, a rather devastating cellular oxidant; thus, 
saving the cells/tissues from oxidative damage (Castillo et al., 2007; 
Sandoval et al., 1997). 
Ceramide, one of the products of SMase activty, is an 
endogenous pyrogen (Sanchez-Alavez, et al., 2006). It is also a 
FIGURE 1 Inhibitory effect of the selected extracts on 
sphinogomyelinase. Results are presented as mean ± SEM of 
triplicate experiments. 
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major factor in the cellular signalling pathways of inflammation, 
oxidative stress (Ichi et al., 2009), and apoptosis (Jones et al., 1999), 
as well as in all the metabolic and pathophysiological pathways 
modulated by these states and events in the individual (Barth et al., 
2012; Fox et al., 2006). These include pathways regulated by such 
pro-inflammatory cytokines as TNF-α (Barth et al., 2012), 
interleukin 1 (IL-1) (Grassme et al., 2003; Hofmeister et al., 1997), 
and IL-6 (Smith and Schuchman, 2008). 
 
Only further testing will determine if the extracts‟ radical 
scavenging and superoxide quenching potencies would be 
protective against radical/oxidative stress – induced injury.  The 
claims of the herbalists to the effect that any of these herbs can be 
employed for successful treatment of the various ailments may have 
a theoretical basis but as of yet remain untested scientifically.  The 
present findings reported herein, therefore, constitute a point at 
which to begin to design the appropriate experiments for 
unravelling further details. 




IC50 value for inhibitory potential 
(μg/ml) 
 DPPH radical Superoxide anion 
(O2
.-) 
Landolphia owariensis 8.3 ± 1.1 58.2 ± 1.8 
Senna siamea 12.4 ± 1.7 52.7 ± 1.4 
Aloe vera 19.6 ± 1.9 285.3 ± 3.4 
Stachytarpheta 
angustifolia 
9.6 ± 1.0 64.6 ± 1.5 
Azadirachta indica 38.4 ± 2.3 18.9 ± 4.3 
Standard anti-oxidant 4.1 ± 0.3* 3.3 ± 0.2** 
Data represented as mean ± SEM (n = 3); *compared to ascorbic 
acid; **compared to rutin 
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